Literature DB >> 8135428

The effect of 25 grams i.v. glucose on serum inorganic phosphate levels.

D B MacLeod1, D R Montoya, G H Fick, K R Jessen.   

Abstract

STUDY
OBJECTIVE: To determine whether a 25-g IV glucose bolus will result in a fall in serum inorganic phosphate levels.
DESIGN: Single-blind, randomized, controlled trial. PARTICIPANTS: Thirty-six healthy, nondiabetic, adult volunteers.
INTERVENTIONS: Random allocation to a control group receiving a 50-mL normal saline bolus followed by a normal saline infusion at 125 mL/hr for three hours; study group 1, receiving a 50-mL bolus of D50W followed by a normal saline infusion at 125 mL/hr for three hours; or study group 2, receiving a 50-mL bolus of D50W followed by an infusion of 2/3:1/3 dextrose:saline solution at 125 mL/hr for three hours.
MEASUREMENTS AND MAIN RESULTS: Serum inorganic phosphate levels were measured at time zero (baseline) and at 30-minute intervals for three hours. There was a statistically significant fall in serum inorganic phosphate levels in both groups receiving the glucose bolus. The group receiving the glucose infusion demonstrated a trend toward a further decline in serum phosphate levels.
CONCLUSION: A glucose bolus and infusion in the amounts compatible with what is given to patients with altered levels of consciousness produced a significant fall in serum inorganic phosphate levels in healthy, nondiabetic adults. Because hypophosphatemia may create a clinical picture of altered mental status very similar to that of hypoglycemia, consideration should be given to administering IV glucose only to patients with finger-stick-proven hypoglycemia. Consideration also should be given to monitoring phosphate levels after administration of IV glucose.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8135428     DOI: 10.1016/s0196-0644(94)70072-9

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  5 in total

Review 1.  Working group reports: evaluation of the evidence to support practice guidelines for nutritional care of preterm infants-the Pre-B Project.

Authors:  Daniel J Raiten; Alison L Steiber; Susan E Carlson; Ian Griffin; Diane Anderson; William W Hay; Sandra Robins; Josef Neu; Michael K Georgieff; Sharon Groh-Wargo; Tanis R Fenton
Journal:  Am J Clin Nutr       Date:  2016-01-20       Impact factor: 7.045

Review 2.  Severe hypophosphatemia associated with gallstone pancreatitis: a case report and review of the literature.

Authors:  David A Steckman; Jenifer L Marks; Mike K Liang
Journal:  Dig Dis Sci       Date:  2006-04-27       Impact factor: 3.199

3.  Cord blood calcium, phosphate, magnesium, and alkaline phosphatase gestational age-specific reference intervals for preterm infants.

Authors:  Tanis R Fenton; Andrew W Lyon; M Sarah Rose
Journal:  BMC Pediatr       Date:  2011-08-31       Impact factor: 2.125

Review 4.  Drugs and pharmaceuticals: management of intoxication and antidotes.

Authors:  Silas W Smith
Journal:  EXS       Date:  2010

5.  Phosphorus bioaccessibility measured in four amino acid-based  formulas using in-vitro batch digestion translates well into phosphorus bioavailability in mice.

Authors:  Sampada Chande; Francina Dijk; Jonathan Fetene; Steven Yannicelli; Thomas O Carpenter; Ardy van Helvoort; Clemens Bergwitz
Journal:  Nutrition       Date:  2021-04-28       Impact factor: 4.893

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.